Skip to main content
Premium Trial:

Request an Annual Quote

Correlagen Partners with Children s Hospital Boston to Clinically Validate Genetic Tests

NEW YORK, Sept. 12 (GenomeWeb News) - Correlagen Diagnostics said today that it has signed a collaborative agreement with Children's Hospital Boston to explore the use of genetic testing in the clinic.

 

The partners intend to study the "clinical validity" of genetic diagnostics for certain diseases, and to discover correlations between genetic variation and disease phenotypes, the company said.

 

Correlagen said it will also provide sequence-based diagnostic assays to investigators at Children's Hospital for research purposes.

 

The company said it has the right to commercialize any diagnostic tests that arise from certain of these research programs.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.